RONAN O'CAOIMH, CHAIRMAN, co-founded Trinity Biotech in 1992 and acted as CFO until 1994 when he became CEO. Prior to joining Trinity, Mr. O'Caoimh was Managing Director of Noctech Limited, an Irish diagnostics company. Mr. O'Caoimh holds a Bachelor of Commerce degree from University College, Dublin and is a Fellow of the Institute of Chartered Accountants in Ireland.

BRENDAN FARRELL, CHIEF EXECUTIVE OFFICER, joined Trinity Biotech in 1994. He was previously Marketing Director of B.M. Browne Limited, a company involved in the marketing and distribution of medical and diagnostic products. Prior to that he was CEO of Noctech Limited, following six years with Baxter Healthcare where he was Director of European Business Development. Mr Farrell has a Masters degree in Biochemistry from University College Cork.

RORY NEALON, CHIEF OPERATING OFFICER, joined Trinity Biotech in early 2003 from Conduit plc, a telecom services company where he was CFO. Previously Mr.Nealon was employed by Allied Irish Banks plc where he invested equity and short-term mezzaine finance into emerging growth companies. Mr. Nealon holds a Bachelor of Commerce degree from University College Dublin, is a Fellow of the Institute of Chartered Accountants in Ireland, the Institute of Taxation in Ireland and the U.K. Institute of Corporate Treasurers.

KEVIN TANSLEY, CHIEF FINANCIAL OFFICER, joined Trinity Biotech in 2003 as Chief Accounting Officer. Previously Mr. Tansley was employed by ESB, Ireland's premier electricity utility, where he held a number of financial positions. Mr. Tansley holds a Masters in Accounting from University College Dublin and trained as a chartered accountant in Arthur Andersen. Mr. Tansley is a Fellow of the Institute of Chartered Accountants in Ireland.

JIM WALSH, PHD, NON-EXECUTIVE DIRECTOR, joined Trinity Biotech in October 1995. Prior to joining the Company, Dr. Walsh was Managing Director of Cambridge Diagnostics Ireland Limited (CDIL). He was employed with CDIL since 1987. Before joining CDIL he worked with fleming GmbH as Research & Development Manager. Dr. Walsh has a degree in Chemistry and a PhD in Microbiology from University College Galway.

DENIS R. BURGER, PHD, NON-EXECUTIVE DIRECTOR, co-founded Trinity Biotech in June 1992 and acted as Chairman from June 1992 to May 1995. He is currently a non-executive director of the Company. Dr Burger is Chairman, Chief Executive Officer and a director of AVI Biopharma Inc, an Oregon based biotechnology company. Dr Burger is also a 50% partner in Sovereign Ventures, a healthcare consulting and unding firm based in Portland, Oregon. He was a co-founder and, from 1981 to 1990, Chairman of Epitope Inc. In addition, Dr Burger has held a professorship in the Department of Microbiology and Immunology and Surgery (Surgical Oncology) at the Oregon Health Sciences University in Portland. Dr Burger received his degree in Bacteriology and Immunology from the University of California in Berkeley in 1965 and his Master of Science and PhD in 1969 in Microbiology and Immunology from the University of Arizona.

PETER COYNE, NON-EXECUTIVE DIRECTOR, joined the board of Trinity Biotech in November 2001 as a non-executive director. Mr Coyne is a director of AIB Corporate Finance, a subsidiary of AIB Group plc, the Irish banking group. He has extensive experience in advising public and private groups on all aspects of corporate strategy. Prior to joining AIB, Mr Coyne trained as a chartered accountant and was a senior manager in Arthur Andersen's Corporate Financial Services practice. Mr Coyne holds a Bachelor of Engineering degree from University College Dublin and is a Fellow of the Institute of Chartered Accountants in Ireland.